# Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis

> **NCT00202410** · PHASE2,PHASE3 · COMPLETED · sponsor: **S. Andrea Hospital** · enrollment: 80 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Bacille of Calmette-Guerin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00202410
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2007-09
- **Final completion:** 2008-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202410, "Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00202410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*